|
|
Addiction to Benzodiazepines—How Common?
August Piper, Jr, MD
Arch Fam Med. 1995;4(11):964-970.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Lader M. Dependence on benzodiazepines. J Clin Psychiatry. 1983;44:121-127.
PUBMED
2. Tyrer P, Murphy S. The place of benzodiazepines in psychiatric practice. Br J Psychiatry. 1987;151:719-723.
FREE FULL TEXT
3. Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs. 1983;25:385-398.
PUBMED
4. Hollister LE, Müller-Oerlinghausen B, Rickels K, Shader R. Clinical uses of benzodiazepines. J Clin Psychopharmacol. 1993;13(suppl_1):1S-169S.
PUBMED
5. DuPont R. Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse. 1988;14(suppl 1):1-69.
PUBMED
6. Farnsworth MG. Benzodiazepine abuse and dependence: misconceptions and facts. J Fam Pract. 1990;31:393-400.
PUBMED
7. Talley JH. But what if a patient gets hooked? Postgrad Med. 1990;87:187-204.
PUBMED
8. Clinthorne JK, Cisin IH, Balter MB, Mellinger GD, Uhlenhuth EH. Changes in popular attitudes and beliefs about tranquilizers, 1970-1979. Arch Gen Psychiatry. 1986;43:527-532.
FREE FULL TEXT
9. Angermeyer MC, Däumer R, Matschinger H. Benefits and risks of psychotropic medication in the eyes of the Federal Republic: results of a survey in the Federal Republic of Germany. Pharmacopsychiatry. 1993;26:114-120.
PUBMED
10. Manheimer DI, Davidson ST, Baiter MB, Mellinger GD, Cisin IH, Parry HJ. Popular attitudes and beliefs about tranquilizers. Am J Psychiatry. 1973;130:1246-1253.
FREE FULL TEXT
11. Rifkin A. Benzodiazepines for anxiety disorders: are the concerns justified? Postgrad Med. 1990;87:209-219.
PUBMED
12. Piper A. 'Addication' to benzodiazepines: a critique of Consumer Reports' 'high anxiety.' J Clin Psychopharmacol. 1994;14:290-291.
PUBMED
13. King MB. Is there still a role for benzodiazepines in general practice? Br J Gen Pract. 1992;42:202-205.
PUBMED
14. Uhlenhuth EB, De Wit H, Baiter MB, Johanson CE, Mellinger GD. Risks and benefits of longterm benzodiazepine use. J Clin Psychopharmacol. 1988;8:161-167.
PUBMED
15. Ballenger JC, Pecknold J, Rickels K, Sellers EM. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993;54(suppl 10):15-21.
PUBMED
16. Juergens SM. Benzodiazepines and addication. Psychiatr Clin North Am. 1993;16:75-86.
PUBMED
17. Essig CF. Addiction to nonbarbiturate sedative and tranquilizing drugs. Clin Pharmacol Ther. 1964;5:334-343.
PUBMED
18. Roache JD. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics. Adv Alcohol Subst Abuse. 1990;9:103-128.
PUBMED
19. Smith DE, Wesson DR. A new method for treatment of barbiturate dependence. JAMA. 1970;213:294-295.
FREE FULL TEXT
20. Clare AW. Diazepam, alcohol, and barbiturate abuse. BMJ. 1971;4:340.
FREE FULL TEXT
21. Woody GE, O'Brien CP, Greenstein R. Misuse and abuse of diazepam: an increasingly common medical problem. Int J Addict. 1975;10:843-48.
PUBMED
22. Juergens SM, Morse RM. Alprazolam dependence in seven patients. Am J Psychiatry. 1988;145:625-627.
FREE FULL TEXT
23. Landry MJ, Smith DE, McDuff DR, Baughman OL. Benzodiazepine dependence and withdrawal: identification and medical management. J Am Board Fam Pract. 1992;5:167-176.
PUBMED
24. Hohagen F, Montero RM, Weiss E, et al. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics. Eur Arch Psychiatry Clin Neurosci. 1994;244:65-72.
PUBMED
25. Alexanian D, Voss E, Schiedermayer D. The benzodiazepine-addicted patient in general practice. Wis Med J. April 1993:188-192. 26. Gitlin MJ. The Psychotherapist's Guide to Psychopharmacology. New York, NY: Free Press; 1990:106, 155, 269. 27. Miller NS, Gold MS. Benzodiazepines: a major problem. J Subst Abuse Treat. 1991;8:3-7.
PUBMED
28. Miller NS, Gold MS. Benzodiazepines: reconsidered. Adv Alcohol Subst Abuse. 1990;8:67-84.
PUBMED
29. Miller NS, Mahler JC. Addiction to and dependence on benzodiazepines. J Subst Abuse Treat. 1991;8:61-67.
PUBMED
30. Miller NS, Gold MS. Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. Am J Drug Alcohol Abuse. 1991;17:27-37.
PUBMED
31. Maletzky BM, Klotter J. Addiction to diazepam. Int J Addict. 1976;11:95-115.
PUBMED
32. Gordon B. I'm Dancing as Fast as I Can. New York, NY: Perennial Library; 1979. 33. The AA member: Medications and Other Drugs: A Report From a Group of Physicians in AA. New York, NY: AA Grapevine; 1984. 34. Kleber HD. The nosology of abuse and dependence. J Psychiatr Res. 1990;24(suppl 2):57-64.
PUBMED
35. Rinaldi RC, Steindler EM, Wilford BB, Goodwin D. Clarification and standardization of substance-abuse terminology. JAMA. 1988;257:555-557.
36. Woody G, Schuckit M, Weinrieb R, Yu E. A review of the substance-use disorders section of the DSM-IV. Psychiatr Clin North Am. 1993;16:21-32.
PUBMED
37. L'Abate LL, Farrar JE, Serritella DA. Handbook of Differential Treatments for Addictions. Boston, Mass: Allyn & Bacon; 1992:2. 38. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symptom Manage. 1990;5(suppl 1):S2-S5.
PUBMED
39. Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: its significance and characteristics. Bull World Health Organ. 1965;32:721-733.
PUBMED
40. Dickinson B, Rush PA, Radcliffe AB. Alprazolam use and dependence: a retrospective analysis of 30 cases of withdrawal. West J Med. 1990;152:604-608.
PUBMED
41. Portenoy RK, Payne R. Acute and chronic pain. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. 2nd ed. Baltimore, Md: Williams & Wilkins; 1992:691-721. 42. Roy-Byrne PP, Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med. 1988;84:1041-1052.
PUBMED
43. DuPont RL. A practical approach to benzodiazepine discontinuation. J Psychiatr Res. 1990;24(suppl 2):81-90.
PUBMED
44. Jaffe, JH. Drug addiction and drug abuse. In: Gilman AG, Rail TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Macmillan Publishing Co Inc; 1990:522-573. 45. Miller NS, Dackis CA, Gold MS. The relationship of addiction, tolerance, and dependence to alcohol and drugs: a neurochemical approach. J Subst Abuse Treat. 1987;4:197-207.
PUBMED
46. Lickey ME, Gordon B. Drugs for Mental Illness: A Revolution in Psychiatry. New York, NY: WH Freeman; 1983:241. 47. Committee of the Institute for Behavior and Health Inc. Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse. 1988;14(suppl 1):1-69.
PUBMED
48. Higgitt AC, Lader MH, Fonagy P. Clinical management of benzodiazepine dependence. BMJ. 1985;291:688-690.
FREE FULL TEXT
49. Haskell D, Cole JO, Schniebolk S, Lieberman B. A survey of diazepam patients. Psychopharmacol Bull. 1986;22:434-438.
PUBMED
50. Woods JH, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacol Rev. 1987;39:251-413.
PUBMED
51. Noyes R, Garvey MJ, Cook BL, Perry PJ. Benzodiazepine withdrawal: a review of the evidence. J Clin Psychiatry. 1988;49:382-389.
PUBMED
52. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet. 1985;1:1042-1043.
PUBMED
53. Busto U. Sellers EM, Naranjo C, Cappell H, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986;315:854-859.
ABSTRACT
54. Schweizer E, Case WG, Rickels K. Benzodiazepine dependence and withdrawal in elderly patients. Am J Psychiatry. 1989;146:529-531.
FREE FULL TEXT
55. Rickels K, Case WG, Downing RW, Winokur A. Long-term diazepam therapy and clinical outcome. JAMA. 1983;250:767-771.
FREE FULL TEXT
56. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines, II: effects of gradual taper. Arch Gen Psychiatry. 1990;47:908-915.
FREE FULL TEXT
57. Roy-Byrne PP. Benzodiazepine dependence. J Am Board Fam Pract. 1992;5:225-227.
PUBMED
58. Pecknold JC. Discontinuation studies: shortterm and long-term. J Psychiatr Res. 1990;24:80-81.
PUBMED
59. Cormack MA, Sweeny KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44:5-8.
PUBMED
60. Nagy A. Long-term treatment with benzodiazepines: theoretical, ideological, and practical aspects. Acta Psychiatr Scand. 1987;76(suppl 335):47-55.
61. Haefely W. Biological basis of drug-induced tolerance, rebound, and dependence: contribution of recent research on benzodiazepines. Pharmacopsychiatry. 1986;19:353-361.
PUBMED
62. Raftery EB. Cardiovascular drug withdrawal syndromes: a potential problem with calcium antagonists? Drugs. 1984;28:371-374.
PUBMED
63. Lupolover R, Dazzi H, Ward J. Rebound phenomena: results of a 10 years' (1970-1980) literature review. Int Pharmacopsychiatry. 1982;17:194-237.
PUBMED
64. Kräupl Taylor F. The damnation of benzodiazepines. Br J Psychiatry. 1989;154:697-704.
FREE FULL TEXT
65. Keuthen N, Cyr P, Ricciardi JA, Minichiello NE, Buttolf ML, Jenike MA. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine. J Clin Psychopharmacol. 1994;14:206-207.
PUBMED
66. Garner EM, Kelly MW, Thompson DF. Tricyclic antidepressant withdrawal syndrome. Ann Pharmacother. 1993;27:1068-1072.
ABSTRACT
67. de Leon J. Anticholinergics to treat clozapine withdrawal. J Clin Psychiatry. 1994;55:119-120.
PUBMED
68. Dilsaver SC. Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology. Acta Psychiatr Scand. 1988;78:1-7.
PUBMED
69. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med. 1993;328:1398-1405.
FREE FULL TEXT
70. Salzman C. Issues and controversies regarding benzodiazepine use. NIDA Res Monogr. 1993;131:68-88.
PUBMED
71. American Psychiatric Association. Benzodiazepine Dependence, Toxicity, and Abuse: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1990. 72. DuPont RL. Benzodiazepines, addiction, and public policy. N J Med. 1993;90:823-826.
PUBMED
73. Ross HE. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction. 1993;88:209-218.
PUBMED
74. Ciraulo DA, Sands BF, Shader DI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988;145:1501-1506.
FREE FULL TEXT
75. Woods JH, Katz JL, Winger G. Use and abuse of benzodiazepines: issues relevant to prescribing. JAMA. 1988;260:3476-3480.
FREE FULL TEXT
76. Balmer R, Battegay R, von Marschall R. Longterm treatment with diazepam: investigation of consumption habits and the interaction between psychotherapy and psychopharmacotherapy: a prospective study. Int Pharmacopsychiatry. 1981;16:221-234.
PUBMED
77. Winstead DK, Anderson A, Eilers K, Blackwell B, Zaremba AL. Diazepam on demand: drugseeking behavior in psychiatric inpatients. Arch Gen Psychiatry. 1974;30:349-351.
FREE FULL TEXT
78. Ballenger JC, Burrows GD, DuPont RL, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, I: efficacy in short-term treatment. Arch Gen Psychiatry. 1988;45:413-422.
FREE FULL TEXT
79. Romach MK, Busto UE, Sobell LC, Sobell MB, Somer GR, Sellers EM. Long-term alprazolam use: abuse, dependence or treatment? Psychopharmacol Bull. 1991;27:391-395.
PUBMED
80. Nolan L, O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol. 1988;35:225-229.
PUBMED
81. Geiselmann B, Linden M. Prescription and intake patterns in long-term and ultra-long-term benzodiazepine treatment in primary care practice. Pharmacopsychiatry. 1991;24:55-61.
PUBMED
82. Laux G, König W. Long-term use of benzodiazepines in psychiatric inpatients. Acta Psychiatr Scand. 1987;76:64-70.
PUBMED
83. Rifkin A, Seshagiri D, Basawaraj K, Hasan N, Alvarez L. Benzodiazepine use and abuse by patients at outpatient clinics. Am J Psychiatry. 1987;146:1331-1332.
84. Wolf B, Grohmann R, Biber D, Brenner PM, Rüther E. Benzodiazepine abuse and dependence in psychiatric inpatients. Pharmacopsychiatry. 1989;22:54-60.
PUBMED
85. Caplan RD, Andrews FM, Conway TL, Abbey A, Abramis DJ, French JRP. Social effects of diazepam use: a longitudinal field study. Soc Sci Med. 1985;21:887-898.
PUBMED
86. Bowden CL, Fisher JG. Safety and efficacy of long-term diazepam therapy. South Med J. 1980;73:1581-1584.
PUBMED
87. Mellinger GD, Baiter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA. 1984;251:375-379.
FREE FULL TEXT
88. DuPont RL, Swinson RP, Ballenger JC, et al. Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992;12:352-354.
PUBMED
89. Lucki I, Rickels K. The behavioral effects of benzodiazepines following long-term use. Psychopharmacol Bull. 1986;22:424-432.
PUBMED
90. Rickels K, Schweizer E, Csanalosi I, Case G, Chung H. Long-term treatment of anxiety and risk of withdrawal: prospective evaluation of chlorazepate and buspirone. Arch Gen Psychiatry. 1988;45:444-450.
FREE FULL TEXT
91. Cole JO, Chiarello RJ. The benzodiazepines as drugs of abuse. J Psychiatr Res. 1990:24 (suppl 2):135-144.
PUBMED
92. De Wit H, Uhlenhuth EH, Hedeker D, McCracken SG, Johansen CE. Lack of preference for diazepam in anxious volunteers. Arch Gen Psychiatry. 1986;43:533-541.
FREE FULL TEXT
93. Prescott LF. Safety of the benzodiazepines. In: Costa E, ed. The Benzodiazepines: From Molecular Biology to Clinical Practice. New York, NY: Raven Press; 1983:253-265. 94. Gudex C. Adverse effects of benzodiazepines. Soc Sci Med. 1991;33:587-596.
PUBMED
95. Cole JD, Kando JC. Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. J Clin Psychiatry. 1993;54 (suppl 10):49-61.
PUBMED
96. Van Der Bijl P, Roelofse JA. Disinhibitory reactions to benzodiazepines: a review. J Oral Maxillofacial Surg. 1991;49:519-523.
PUBMED
97. Curran HV. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol. 1986;23:179-213.
PUBMED
98. Marks J. Chronic anxiolytic treatment: benefit and risk. In: Kemali D, Racagni G, eds. Chronic Treatments in Neuropsychiatry. New York, NY: Raven Press; 1985:173-183. 99. Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J Psychiatr Res. 1993;27(suppl 1):97-110.
PUBMED
100. Warneke LB. Benzodiazepines: abuse and new use. Can J Psychiatry. 1991;36:194-205.
PUBMED
101. Rosenbaum JF. Benefit/risk issues: clinical perspectives. J Psychiatr Res. 1993;27(suppl 1):38-39.
102. Ballenger JC, Pecknold J, Rickels K, Sellers EM. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993;54(suppl 10):15-21.
PUBMED
103. Tyrer P. Dependence on benzodiazepines. Br J Psychiatry. 1980;137:576-577.
FREE FULL TEXT
104. Lader M, Petursson H. Long-term effects of benzodiazepines. Neuropharmacology. 1983;22:527-533.
PUBMED
105. Gorman JM, Papp LA. Chronic anxiety: deciding the length of treatment. J Clin Psychiatry. 1990;51(suppl 1):11-15.
106. Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand. 1991;84:446-452.
PUBMED
107. Tyrer P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. BMJ. 1989;298:102-105.
FREE FULL TEXT
108. Rickels K, Case G, Downing RW, Fridman R. One-year follow-up of anxious patients treated with diazepam. J Clin Psychopharmacol. 1986;6:32-36.
PUBMED
109. Rickels K, Schweizer E. The clinical course and long-term managment of generalized anxiety disorder. J Clin Psychopharmacol. 1990;109 (suppl 3):101S-110S.
110. Edwards G, Arif A, Hodgson R. Nomenclature and classification of drug- and alcohol-related problems: a WHO memorandum. Bull World Health Organ. 1981;59:225-242.
PUBMED
111. DuPont RL, DuPont CM. The treatment of anxiety: realistic expectations and risks posed by controlled substances. J Law Med Ethics. 1994;22:206-214.
FREE FULL TEXT
|